Search Results - "Neitzel, Nickolas A"
-
1
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy
Published in Cancer discovery (04-08-2023)“…Rationally targeted therapies have transformed cancer treatment, but many patients develop resistance through bypass signaling pathway activation. PF-07284892…”
Get more information
Journal Article -
2
Discovery of 5‑Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors
Published in ACS medicinal chemistry letters (14-12-2023)“…SHP2 has emerged as an important target for oncology small-molecule drug discovery. As a nonreceptor tyrosine phosphatase within the MAPK pathway, it has been…”
Get full text
Journal Article -
3
Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator
Published in Bioorganic & medicinal chemistry (01-01-2020)“…[Display omitted] Glucose flux through glucokinase (GK) controls insulin release from the pancreas in response to high levels of glucose. Flux through GK is…”
Get full text
Journal Article